Isomorphic Labs and Google DeepMind have unveiled AlphaFold 3, a powerful AI system that draws on a novel diffusion-based architecture to accurately model the structures of complexes containing proteins, nucleic acids, DNA and RNA strands, small molecules, ions and modified residues. Diffusion models are a type of generative model that has won significant popularity in…
AlphaFold: Redefining drug discovery with digital biology and AI
At the Nvidia GTC 2023, DeepMind’s Founder and CEO, Demis Hassabis, provided an in-depth look into the seismic potential of their protein folding AI system, AlphaFold. Hassabis said AlphaFold was a contender for the organization’s “biggest project to date.” Hassabis noted that DeepMind’s AlphaFold has made strides in addressing the protein folding problem, a challenge…
7 ways DeepMind’s AlphaFold is being used in life sciences
Alphabet subsidiary DeepMind has announced that its AI system AlphaFold has predicted the structure of more than 200 million proteins, representing almost every known cataloged protein. In addition, AlphaFold and its partner, the EMBL‘s European Bioinformatics Institute, announced that the recent release expanded the database by more than 200 fold, from almost 1 million to…
How a Google AI program for protein folding could speed drug discovery
A Google-owned lab has accurately predicted protein structures, potentially paving the way toward advances in drug discovery. London-based DeepMind lab has developed a deep-learning program known as AlphaFold that bested roughly 100 efforts to predict protein structures in a contest known as Critical Assessment of Structure Prediction (CASP). Such proteins are found within the cells…